SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-016491
Filing Date
2024-12-27
Accepted
2024-12-27 16:30:27
Documents
84
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-K otlk-20240930x10k.htm   iXBRL 10-K 2331626
2 EX-4.1 otlk-20240930xex4d1.htm EX-4.1 44618
3 EX-10.11 otlk-20240930xex10d11.htm EX-10.11 39572
4 EX-19.1 otlk-20240930xex19d1.htm EX-19.1 93912
5 EX-21.1 otlk-20240930xex21d1.htm EX-21.1 5202
6 EX-23.1 otlk-20240930xex23d1.htm EX-23.1 2782
7 EX-31.1 otlk-20240930xex31d1.htm EX-31.1 13493
8 EX-32.1 otlk-20240930xex32d1.htm EX-32.1 8056
9 GRAPHIC otlk-20240930x10k006.jpg GRAPHIC 49932
10 GRAPHIC otlk-20240930x10k007.jpg GRAPHIC 51929
  Complete submission text file 0001558370-24-016491.txt   9135495

Data Files

Seq Description Document Type Size
11 EX-101.SCH otlk-20240930.xsd EX-101.SCH 47101
12 EX-101.CAL otlk-20240930_cal.xml EX-101.CAL 55488
13 EX-101.DEF otlk-20240930_def.xml EX-101.DEF 204484
14 EX-101.LAB otlk-20240930_lab.xml EX-101.LAB 425620
15 EX-101.PRE otlk-20240930_pre.xml EX-101.PRE 372168
87 EXTRACTED XBRL INSTANCE DOCUMENT otlk-20240930x10k_htm.xml XML 1423755
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37759 | Film No.: 241586021
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)